Aerospace Force's mission in Syria more effective than American - press secretary
Politician warns Ukraine will face huge losses, job cuts due to ban on exports to Russia
Turkish businesses ring tocsins - Russian presidential press secretary
Islamic State gunmen receive weapons from Turkey — Syria FM
Head of Crimea hopes power bridge will start operating on December 5-6
Chechnya’s leader says Turkey provides assistance to terroristsRussian Politics & Diplomacy November 28, 21:47
Aerospace Force's mission in Syria more effective than American - press secretaryRussian Politics & Diplomacy November 28, 15:59
Turkish businesses ring tocsins - Russian presidential press secretaryRussian Politics & Diplomacy November 28, 9:33
OSCE conf giving Russia, Turkey chance to straighten out relations — Serbia's PresidentWorld November 28, 3:03
NATO understands that Turkey creates risks for entire alliance — Russian NATO envoyRussian Politics & Diplomacy November 28, 0:45
Syria FM says incident with Russian plane act of aggression against Syria's sovereignityWorld November 27, 21:45
Russian Foreign Ministry: No conditions for modernization of trust-building agreementRussian Politics & Diplomacy November 27, 21:35
Head of Crimea hopes power bridge will start operating on December 5-6Business & Economy November 27, 21:29
Russia’s Aerospace Forces chief: Turkish F-16 didn't warn Su-24M crew at agreed frequencyMilitary & Defense November 27, 20:55
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.